Vanguard Group Inc Stereotaxis, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Stereotaxis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,302,609 shares of STXS stock, worth $9.45 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,302,609
Previous 3,534,291
6.56%
Holding current value
$9.45 Million
Previous $6.22 Million
12.56%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding STXS
# of Institutions
94Shares Held
42MCall Options Held
21.9KPut Options Held
18.6K-
Dafna Capital Management LLC Los Angeles, CA13.7MShares$39.1 Million8.43% of portfolio
-
Lagoda Investment Management, L.P. New York, NY4.69MShares$13.4 Million5.81% of portfolio
-
Black Rock Inc. New York, NY3.54MShares$10.1 Million0.0% of portfolio
-
Arbiter Partners Capital Management LLC New York, NY2.85MShares$8.16 Million14.02% of portfolio
-
Essex Investment Management CO LLC Boston, MA1.54MShares$4.42 Million0.67% of portfolio
About Stereotaxis, Inc.
- Ticker STXS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,790,096
- Market Cap $214M
- Description
- Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by pr...